FC
Foresite Capital Management VI LLC
WEST HOLLYWOOD CA · SEC CIK 0002013341
$642.58M2026Q2 reported value
23Positions
81.5%Top 10 weight · largest 26.2%
4 / 2New / sold out
26Q126Q2
Top 10 holdings % of portfolio
2026Q2 top buys estimated at quarter-end value
CLDX Added+$20.98M
GHRS Added+$16.80M
JBIO Added+$12.59M
BEAM New+$11.33M
CGON Added+$10.52M
2026Q2 top sells estimated at quarter-end value
Centessa Pharmac Sold out-$54.18M
OKUR Sold out-$5.99M
NERV Reduced-$5,639
2026Q2 holdings click a header to sort
Export CSV 🔒| Ticker | Name | Value ▼ | Weight | Shares | Share change | Change | Est. flow | Action |
|---|---|---|---|---|---|---|---|---|
| CGON | CG Oncology, Inc. | $168.36M | 26.20% | 2,369,574 | 148,100 | 6.7% | $10.52M | Added |
| ALMS | ALUMIS INC. | $119.53M | 18.60% | 4,247,670 | 0 | 0.0% | — | Unchanged |
| SPTX | Seaport Therapeutics, Inc. | $38.65M | 6.02% | 1,779,521 | 1,779,521 | — | — | First reported |
| DNLI | Denali Therapeutics Inc. | $35.92M | 5.59% | 1,396,771 | 186,800 | 15.4% | $4.80M | Added |
| CLDX | Celldex Therapeutics, Inc. | $32.73M | 5.09% | 879,713 | 563,800 | 178.5% | $20.98M | Added |
| AGIO | AGIOS PHARMACEUTICALS, INC. | $29.13M | 4.53% | 785,000 | 260,000 | 49.5% | $9.65M | Added |
| CRVS | Corvus Pharmaceuticals, Inc. | $27.36M | 4.26% | 1,831,233 | 0 | 0.0% | — | Unchanged |
| PBLS | Parabilis Medicines, Inc. | $27.34M | 4.26% | 999,044 | 999,044 | — | — | First reported |
| GHRS | GH Research PLC | $25.28M | 3.93% | 940,493 | 625,001 | 198.1% | $16.80M | Added |
| JBIO | Jade Biosciences, Inc. | $19.70M | 3.07% | 886,667 | 566,667 | 177.1% | $12.59M | Added |
| HNGE | Hinge Health, Inc. | $18.29M | 2.85% | 220,400 | 0 | 0.0% | — | Unchanged |
| KYMR | Kymera Therapeutics, Inc. | $16.78M | 2.61% | 146,332 | 0 | 0.0% | — | Unchanged |
| — | AtaiBeckley Inc. | $14.49M | 2.26% | 2,750,000 | 0 | 0.0% | — | Unchanged |
| VSTM | Verastem, Inc. | $12.02M | 1.87% | 3,146,631 | 0 | 0.0% | — | Unchanged |
| BEAM | Beam Therapeutics Inc. | $11.33M | 1.76% | 330,000 | 330,000 | — | $11.33M | New |
| NERV | Minerva Neurosciences, Inc. | $11.02M | 1.71% | 1,985,584 | -1,016 | -0.1% | -$5,639 | Reduced |
| AVBP | ArriVent BioPharma, Inc. | $10.47M | 1.63% | 301,341 | 301,341 | — | $10.47M | New |
| AURA | Aura Biosciences, Inc. | $9.47M | 1.47% | 1,333,334 | 1,333,334 | — | $9.47M | New |
| — | Crinetics Pharmaceuticals, Inc. | $7.93M | 1.23% | 212,010 | 0 | 0.0% | — | Unchanged |
| — | Research Alliance Corp III | $3.21M | 0.50% | 300,000 | 300,000 | — | — | First reported |
| ZURA | Zura Bio Ltd | $2.65M | 0.41% | 450,000 | 0 | 0.0% | — | Unchanged |
| KLRA | Kailera Therapeutics, Inc. | $826,125 | 0.13% | 37,500 | 37,500 | — | — | First reported |
| IRON | Disc Medicine, Inc. | $70,946 | 0.01% | 970 | 970 | — | $70,946 | New |
| — | Centessa Pharmaceuticals plc | $0 | 0.00% | 0 | -1,364,019 | -100.0% | -$54.18M | Sold out |
| OKUR | OnKure Therapeutics, Inc. | $0 | 0.00% | 0 | -1,445,783 | -100.0% | -$5.99M | Sold out |